[1]向小红,吕红彬.雌激素与糖尿病性视网膜病变的研究进展[J].眼科新进展,2017,37(5):496-500.[doi:10.13389/j.cnki.rao.2017.0126]
　XIANG Xiao-Hong,LV Hong-Bin.Recent advances in estrogen and diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(5):496-500.[doi:10.13389/j.cnki.rao.2017.0126]
点击复制

雌激素与糖尿病性视网膜病变的研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
37卷
期数:
2017年5期
页码:
496-500
栏目:
文献综述
出版日期:
2017-05-05

文章信息/Info

Title:
Recent advances in estrogen and diabetic retinopathy
作者:
向小红; 吕红彬
646000　四川省泸州市，西南医科大学附属第一医院眼科
Author(s):
XIANG Xiao-Hong; LV Hong-Bin
Department of Ophthalmology，the First Affiliated Hospital of Southwest Medical University，Luzhou 646000，Sichuan Province，China
关键词:
糖尿病性视网膜病变; 雌激素; 雌激素受体
Keywords:
diabetic retinopathy; estrogen; estrogen receptor
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2017.0126
文献标志码:
A
摘要:
糖尿病性视网膜病变（diabetic retinopathy，DR）是糖尿病所有微血管病变中最严重且常见的致盲性眼部并发症。DR发病机制至今尚未完全明确，其发生与多种因素相关，存在多种学说。近年来DR的发生与性别、激素水平的关系成为眼科研究的热点，研究发现绝经后女性DR患病率明显增加，其中雌激素变化起着主要作用。了解雌激素与DR之间的关系将有助于DR的临床诊疗。本文就雌激素与DR的研究进展作一综述。
Abstract:
Diabetic retinopathy （DR） is the most serious and common blinding ocular complication in all microangiopathy of diabetes mellitus.The occurrence of DR associated with a variety of factors，the pathogenesis has not yet been completely clear，and there are several theories.In recent years，the relationship between the occurrence of DR and sex hormone levels become a hot ophthalmic research，research shows that the prevalence of DR significantly increased in postmenopausal women，in which estrogen change plays the main role.Learning connection between estrogen and DR will contribute to the clinical diagnosis and treatment of DR.This article reviews recent research advances in the relationship between estrogen and DR.

参考文献/References:

［1］　GALETOVIC D，OLUJIC I，ZNAOR L，BUCAN K，KARLICA D，LESIN M，et al.The role of diabetic retinopathy in blindness and poor sight in Split-Dalmatia County 2000-2010［J］.Acta Clin Croat，2013，52（4）：448-452.
［2］　YUEN KK，KAHN HA.The association of female hormones with blindness from diabetic retinopathy［J］.Am J Ophthalmol，1976，81（6）：820-822.
［3］　WILD S，ROGLIC G，GREEN A，SICREE R，KING H.Global prevalence of diabetes：estimates for the year 2000 and projections for 2030［J］.Diabetes Care，2004，27（5）：1047-1053.
［4］　LIEW G，MICHAELIDES M，Bunce C.A comparison of the causes of blindness certifications in England and Wales in working age adults （16-64 years），1999-2000 with 2009-2010［J］.BMJ Open，2013，4（2）：297-301.
［5］　杨宇，田敏，吕红彬.糖尿病视网膜病变的治疗进展［J］.眼科新进展，2015，35（5）：497-500.
YANG Y，TIAN M，LV HB.Advances in treatment of diabetic retinopathy［J］.Rec Adv Ophthal，2015，35（5）：497-500.
［6］　王俊玲，黄思敏，梁启瑶，魏秋实，谭新，邓伟民.雌激素的来源及其在骨代谢中的作用［J］.中国骨质疏松杂志，2015，21（6）：729-732.
WANG JL，HUANG SM，LIANG QY，WEI QS，TAN X，DENG WM.The origin of estrogen and its role in bone metabolism［J］.Chin J Osteopor，2015，21（6）：729-732.
［7］　ZHU C，WANG S，WANG B，DU F，HU C，LI H et al.17beta-estradiol up-regulates Nrf2 via PI3K/AKT and estrogen receptor signaling pathways to suppress light-induced degeneration in rat retina［J］.Neuroscience，2015，304：328-339.
［8］　COX D G，CURTIT E，ROMIEU G，FUMOLEAU P，RIOS M，BONNEFOI H，et al.GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients［J］.Oncotarget，2016，7(47):77358-77364.
［9］　FREDRICK T，KAUR P，MURHEKAR MV，JAYARAMAN Y，KOLANDA -SWAMY K，RAO SR，et al.Diabetic retinopathy and its risk factors in patients with type 2 diabetes attending rural primary healthcare facilities in Tamil Nadu［J］.Natl Med J India，2016，29（1）：9-13.
［10］　TIEN T，BARRETTE KF，CHRONOPOULOS A，ROY S.Effects of high glucose-induced Cx43 downregulation on occludin and ZO-1 expression and tight junction barrier function in retinal endothelial cells［J］.Invest Ophthalmol Vis Sci，2013，54（10）：6518-6525.
［11］　ADAMIEC MJ，ZAJAC PH，MISIUK HM.Caspase-dependent apoptosis of retinal ganglion cells during the development of diabetic retinopathy［J］.Adv Clin Exp Med，2015，24（3）：531-535.
［12］　BADIN PM，VILA IK，SOPARIWALA DH，YADAV V，LORCA S，LOUCHE K，et al.Exercise-like effects by Estrogen-related receptor-gamma in muscle do not prevent insulin resistance in db/db mice［J］.Sci Rep，2016，6：26442.
［13］　SORIANO S，RIPOLL C，FUENTES E，GONZALEZ A，ALONSO MP，ROPERO AB，et al.Regulation of K（ATP） channel by 17beta-estradiol in pancreatic beta-cells［J］.Steroids，2011，76（9）：856-860.
［14］　KOWLURU RA，MISHRA M，KOWURU A，KUMAR B.Hyperlipidemia and the development of diabetic retinopathy：Comparison between type 1 and type 2 animal models［J］.Metabolism，2016，65（10）：1570-1581.
［15］　陈芳.女性绝经后雌激素水平与血脂、血糖和血同型半胱氨酸的关系研究［J］.中国实验诊断学，2016,21（5）：758-760.
CHEN F.Research on the relationship between estrogen levels in postmenopausal women with lipids，blood glucose and blood homocysteine［J］.Chin J Lab Diag，2016，21（5）：758-760.
［16］　XING X，SU L，ASARE PF，WANG L，LI L，LIU E，et al.DZQE activates AMPK pathway and regulates lipid metabolism in a rat model of perimenopausal hyperlipidemia［J］.Exp Physiol，2016，101（11）：1406-1417.
［17］　Gu L，Huang B，Xu Z，Ma X，Pan X.Dissolved organic matter as a terminal electron acceptor in the microbial oxidation of steroid estrogen［J］.Environ Pollut，2016，218（1）：26-33.
［18］　KHAN WA，ALI KM.Cytochrome P450-mediated estrogen metabolites and autoimmunity：relationship and link to free radicals［J］.Curr Drug Metab，2015，17（1）：65-74.
［19］　HERMOSO DA，SHIMADA LB，GILGLIONI EH，CONSTANTIN J，MITO MS，HERMOSO AP，et al.Melatonin protects female rats against steatosis and liver oxidative stress induced by oestrogen deficiency［J］.Life Sci，2016，157：178-186.
［20］　LIAO TL，TZENG CR，YU CL，WANG YP，KAO SH.Estrogen receptor-beta in mitochondria：implications for mitochondrial bioenergetics and tumorigenesis［J］.Ann N Y Acad Sci，2015，1350：52-60.
［21］　NISHIKAWA T，EDELSTEIN D，DU XL，YAMAGISHI S，MATSUMURA T，KANEDA Y，et al.Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage［J］.Nature，2000，404（6779）：787-790.
［22］　DAS JK，FELTY Q.Microvascular lesions by estrogen-induced ID3：its implications in cerebral and cardiorenal vascular disease［J］.J Mol Neurosci，2015，55（3）：618-631.
［23］　PENN JS，MADAN A，CALDWELL RB，BARTOLI M，CALDWELL RW，HARTNETT ME.Vascular endothelial growth factor in eye disease［J］.Prog Retin Eye Res，2008，27（4）：331-371.
［24］　穆华，张晓梅，冯卓蕾，王业青.雌激素对缺氧视网膜Müller细胞PEDF和VEGF表达的影响［J］.国际眼科杂志，2012，12（11）：2066-2068.
MU H，ZHANG XM，FENG ZL，WANG YQ.Effects of estrogen on the expression of PEDF and VEGF in hypoxic retinal Müller cells［J］.Int J Ophthalmolchi，2012，12（11）：2066-2068.
［25］　DE FRANCESCO EM，PELLEGRINO M，SANTOLLA MF，LAPPANO R，RICCHIO E，ABONANTE S，et al.GPER mediates activation of HIF1alpha/VEGF signaling by estrogens［J］.Cancer Res，2014，74（15）：4053-4064.
［26］　DO JY，CHOI YK，KOOK H，SUK K，LEE IK，PARK DH.Retinal hypoxia induces vascular endothelial growth factor through induction of estrogen-related receptor gamma［J］.Biochem Biophys Res Commun，2015，460（2）：457-463.
［27］　MATSUI T，NISHINO Y，MAEDA S，YAMAGISHI S.PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression［J］.Microvasc Res，2012，84 （1）：105-108.
［28］　ZANG J，GUAN G.Study of Pigment Epithelium-derived Factor in Pathogenesis of Diabetic Retinopathy［J］.Eye Sci，2015，30（2）：81-88.
［29］　YOSHIDA Y，YAMAGISHI S，MATSUI T，JINNOUCHI Y，FUKAMI K，IMAIZUMI T，et al.Protective role of pigment epithelium-derived factor （PEDF） in early phase of experimental diabetic retinopathy［J］.Diabetes Metab Res Rev，2009，25（7）：678-686.
［30］　PARVATHANENI K，GRIGSBY JG，BETTS BS，TSIN AT.Estrogen-induced retinal endothelial cell proliferation：possible involvement of pigment epithelium-derived factor and phosphoinositide 3-kinase/mitogen-activated protein kinase pathways［J］.J Ocul Pharmacol Ther，2013，29（1）：27-32.
［31］　ERGUL A.Endothelin-1 and diabetic complications：focus on the vasculature［J］.Pharmacol Res，2011，63（6）：477-482.
［32］　UGURLU N，GERCEKER S，YULEK F，UGURLU B，SARI C，BARAN P，et al.The levels of the circulating cellular adhesion molecules ICAM-1，VCAM-1 and endothelin-1 and the flow-mediated vasodilatation values in patients with type 1 diabetes mellitus with early-stage diabetic retinopathy［J］.Intern Med，2013，52（19）：2173-2178.
［33］　MANEA SA，TODIRITA A，MANEA A.High glucose-induced increased expression of endothelin-1 in human endothelial cells is mediated by activated CCAAT/enhancer-binding proteins［J］.PLoS One，2013，8（12）：84170.
［34］　BARTELLA V，DE FRANCESCO EM，PERRI MG，CURCIO R，DOLCE V，MAGGIOLINI M，et al.The G protein estrogen receptor （GPER） is regulated by endothelin-1 mediated signaling in cancer cells［J］.Cell Signal，2016，28（2）：61-71.
［35］　TAN Z，WANG TH，CHEN Y，LIN GP，PAN JY.Role of NO signal pathway in the inhibitory of 17beta-estradiol on the production of endothelin-1 in vascular smooth muscle cells［J］.Chin J Appl Physiol，2007，23（3）：347-350.
［36］　蒋玲，吕红彬.细胞因子与糖尿病视网膜病变的研究进展［J］.眼科研究，2009，27（12）：1165-1168.
JIAN L，LV HB.Research progress of cytokines and diabetic retinopathy［J］.J Exp Ophthal-Chi，2009，27（12）：1165-1168.
［37］　MATSUDA T，YAMAMOTO T，MURAGUCHI A，SAATCIOGLU F.Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3［J］.J Biol Chem，2001，276（46）：42908-42914.
［38］　苟文军，刘思源，覃冬.泛素-蛋白酶体抑制剂MG132对糖尿病大鼠视网膜上Smad7表达的影响［J］.眼科新进展，2012,32（11）：1014-1016.
GOU WJ，LIU SY，QIN D.Effect of the Ubiquitin-proteasome inhibitor MG132 on retinal Smad7 expression in diabetic rats［J］.Rec Adv Ophthal，2012,32（11）：1014-1016.
［39］　TAM J，DHAMDHERE KP，TIRUVEEDHULA P，LUJAN BJ，JOHNSON RN，BEARSE MJ，et al.Subclinical capillary changes in non-proliferative diabetic retinopathy［J］.Optom Vis Sci，2012，89（5）：692-703.
［40］　江梦南，罗雪，沈雨濛，刘诗量，漏翔峰，胡单萍，等.雌激素受体GPR30介导的小鼠视网膜神经节细胞保护作用［J］.武汉大学学报（医学版），2016，37（2）：195-199.
JIANG ML，LUO X，SHENG YM，LIU SL，LOU XF，HU DP，et al.Protective effects of estrogen receptor GPR30-mediated retinal ganglion cells in mice［J］ J Wuhan Univ（Med），2016，37（2）：195-199.
［41］　葛嫣然，邵宏超，王福海.雌激素对兔缺血再灌注损伤视网膜神经节细胞凋亡的影响及其机制探讨［J］.山东医药，2015，（20）：28-30.
GE YR，SHAO HC，WANG GH.Effects of estrogen on apoptosis of retinal ganglion cells in rabbits with ischemia-reperfusion injury and its mechanism［J］.J Shandong Med，2015，（20）：28-30.
［42］　PROKAI-TATRAI K，XIN H，NGUYEN V，SZARKA S，BLAZICS B，PROKAI L，et al.17beta-estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma［J］.Mol Pharm，2013，10（8）：3253-3261.
［43］　FOUDA AY，ARTHAM S，EI-REMESSY AB，FAGAN SC.Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy：experimental and clinical evidence［J］.Clin Sci （Lond），2016，130（4）：221-238.
［44］　THANGARAJU P，CHAKRABARTI A，BANERJEE D，HOTA D，TAMILSELVAN，BHATIA A，et al.Dual blockade of Renin Angiotensin system in reducing the early changes of diabetic retinopathy and nephropathy in a diabetic rat model［J］.N Am J Med Sci，2014，6（12）：625-632.
［45］　MORENO C，LLINAS M T，RODRIGUEZ F，MORENO JM，SALAZAR FJ.Nitric oxide，prostaglandins and angiotensin Ⅱ in the regulation of renal medullary blood flow during volume expansion［J］.J Physiol Biochem，2016，72（1）：1-8.
［46］　SAMPAIO WO，HENRIQUE DCC，SANTOS RA，SCHIFFRIN EL，TOUYZ RM.Angiotensin-（1-7） counterregulates angiotensin Ⅱ signaling in human endothelial cells［J］.Hypertension，2007，50（6）：1093-1098.
［47］　LEE S，LEE MY，NAM JS，KANG S，PARK JS，SHIN S，et al.Hemorheological approach for early detection of chronic kidney disease and diabetic nephropathy in type 2 diabetes［J］.Diabetes Technol Ther，2015，17（11）：808-815.
［48］　TOPCUOGLU A，ALBAYRAK M，ERMAN H，BALCI H，KARAKUS M，COBAN I，et al.Effects of hormone replacement therapy on plasma and tissue fibrinolytic activity in a rat model of surgically induced menopause［J］.Clin Invest Med，2014，37（2）：85-92.
［49］　JOBE SO，RAMADOSS J，WARGIN AJ，MAGNESS RR.Estradiol-17beta and its cytochrome P450- and catechol-O-methyltransferase-derived metabolites selectively stimulate production of prostacyclin in uterine artery endothelial cells：role of estrogen receptor-alpha versus estrogen receptor-beta［J］.Hypertension，2013，61（2）：509-518.
［50］　VAN DEN BORN JC，HAMMES HP，GREFFRATH W，VAN GOOR H，HILLEBRANDS JL.Gasotransmitters in Vascular Complications of Diabetes［J］.Diabetes，2016，65（2）：331-345.
［51］　谈智，崔雨虹，向秋玲，等.膜雌激素受体介导的NO途径对EPCs增殖和凋亡的影响［J］.中山大学学报（医学科学版），2010，31（1）：64-68.
TAN Z，CUI YH，XIANG QL，LIN GP，WANG TH.Effects of membrane estrogen receptor - mediated NO pathway on proliferation and apoptosis of EPCs［J］.J Sun Yat-Sen Univ （Med Sci），2010，31（1）：64-68.
［52］　HAN Y，LI X，ZHOU S，MENG G，XIAO Y，ZHANG W，et al.17ss-estradiol antagonizes the down-regulation of ERalpha/NOS-3 signaling in vascular endothelial dysfunction of female diabetic rats［J］.PLoS One，2012，7（11）：50402.
［53］　RODRIGUES M，XIN X，JEE K，BABAPOOR-FARROKHRAN S，KASHIWABUCHI F，MA T，et al.VEGF secreted by hypoxic Muller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy［J］.Diabetes，2013，62（11）：3863-3873.
［54］　FANG M，WU X C，HUANG W.Raloxifene upregulated mesangial cell MMP-2 activity via ER-beta through transcriptional regulation［J］.Cell Biochem Biophys，2013，67（2）：607-613.
［55］　MOUNTAIN DJ，KIRKPATRICK SS，FREEMAN MB，STEVENS SL，GOLDMAN MH，GRANDAS OH.Role of MT1-MMP in estrogen-mediated cellular processes of intimal hyperplasia［J］.J Surg Res，2012，173（2）：224-231.

相似文献/References:

[1]张向东 刘海凤 刁婷婷.复方王不留行片联合人工泪液治疗更年期女性眼干燥症的疗效观察[J].眼科新进展,2012,32(7):000.
[2]张 洁 孟小妹 张亦农.重度非增殖性与增殖性糖尿病性视网膜病变多焦视网膜电图一阶函数核的特征分析[J].眼科新进展,2008,28(9):000.
[3]陈娟,吕红彬. 抗VEGF药物在糖尿病性视网膜病变治疗中的应用[J].眼科新进展,2014,34(4):397.[doi:10.13389/j.cnki.rao.2014.0110]
[4]李婷婷,胡健艳,吴强.靶向G蛋白偶联受体91的小发夹RNA慢病毒载体的构建及功能初步检测[J].眼科新进展,2014,34(8):705.[doi:10.13389/j.cnki.rao.2014.0193]
　Li Ting-Ting,HU Jian-Yan,WU Qiang.Construction and identification of shRNA lentiviral vector of G protein-coupled receptor 91[J].Recent Advances in Ophthalmology,2014,34(5):705.[doi:10.13389/j.cnki.rao.2014.0193]
[5]陈明,刘志谦,段志辉,等.玻璃体切割联合保留前囊膜的晶状体切除治疗糖尿病性视网膜病变[J].眼科新进展,2014,34(10):956.[doi:10.13389/j.cnki.rao.2014.0265]
[6]陈小红,王云鹏,陈梅珠. VEGF在糖尿病性视网膜病变发病机制中的作用及抗VEGF治疗新进展[J].眼科新进展,2015,35(7):692.[doi:10.13389/j.cnki.rao.2015.0190]
　CHEN Xiao-Hong,WANG Yun-Peng,CHEN Mei-Zhu. Role of VEGF in pathogenesis of diabetic retinopathy and anti-VEGF therapy[J].Recent Advances in Ophthalmology,2015,35(5):692.[doi:10.13389/j.cnki.rao.2015.0190]
[7]张鹏飞,张杰,高荣玉,等.玻璃体内注射血管内皮生长因子（VEGF）抑制剂治疗糖尿病视网膜病变患者的疗效[J].眼科新进展,2018,38(10):977.[doi:10.13389/j.cnki.rao.2018.0231]
　ZHANG Peng-Fei,ZHANG Jie,GAO Rong-Yu,et al.The efficacy of intravitreal injection of vascular endothelial growth factor （VEGF） inhibitors in patients with diabetic retinopathy[J].Recent Advances in Ophthalmology,2018,38(5):977.[doi:10.13389/j.cnki.rao.2018.0231]
[8]许冬,李浩,周利晓,等.基于卷积神经网络UNet构建糖尿病性黄斑水肿自动识别模型[J].眼科新进展,2020,40(4):357.[doi:10.13389/j.cnki.rao.2020.0082]
　XU Dong,LI Hao,ZHOU Lixiao,et al.Model of automatic identification of diabetic macular edema via convolutional neural networks UNet[J].Recent Advances in Ophthalmology,2020,40(5):357.[doi:10.13389/j.cnki.rao.2020.0082]
[9]李莹莹,蔺晓慧.糖尿病性视网膜病变患者血清中脂肪细胞因子的表达及其影响因素分析[J].眼科新进展,2021,41(1):057.[doi:10.13389/j.cnki.rao.2021.0012]
　LI Yingying,LIN Xiaohui.Expression of adipocytokines in the serum of patients with diabetic retinopathy and its factors[J].Recent Advances in Ophthalmology,2021,41(5):057.[doi:10.13389/j.cnki.rao.2021.0012]
[10]赵立宇,姜茂华,杨芳,等.糖尿病性视网膜病变患者常规全视网膜光凝后黄斑中心凹下脉络膜厚度变化的荟萃分析[J].眼科新进展,2022,42(2):136.[doi:10.13389/j.cnki.rao.2022.0028]
　ZHAO Liyu,JIANG Maohua,YANG Fang,et al.A meta-analysis of changes in the subfoveal choroidal thickness in diabetic retinopathy patients after conventional panretinal photocoagulation[J].Recent Advances in Ophthalmology,2022,42(5):136.[doi:10.13389/j.cnki.rao.2022.0028]

更新日期/Last Update: 2017-06-07